| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.008 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.009 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |